Polatuzumab vedotin 30mg powder for solution for infusion vials

in short Polatuzumab vedotin 30mg inf vials

SNOMED code
39355911000001109
Active compound
Polatuzumab vedotin
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Polatuzumab vedotin — 30 mg based on ingredient substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Polivy 30mg powder for concentrate for solution for infusion vials (Roche Products Ltd)

in short Polivy 30mg pdr for concentrate for inf vials

Polivy 30mg powder for concentrate for solution for infusion vials

SNOMED code
39329411000001102
Supplier
Roche Products Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Polivy 30mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial
39329511000001103   ref. pack
💯 Available

Legal category: POM
07613326027120
7613326027120
NHS Indicative Price
£2,370
• Hospital
  • • Prescription Charges

Reference packs

Polatuzumab vedotin 30mg powder for solution for infusion vials 1 vial
SNOMED code
39329311000001109
Quantity and unit
1 vial
Packs